These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients].
    Author: Xu LP, Huang XJ, Guo NL, Ren HY, Zhang YC, Lu DP.
    Journal: Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):407-9. PubMed ID: 14642176.
    Abstract:
    OBJECTIVE: To evaluate the detection of cytomegalovirus (CMV) by polymerase chain reaction (PCR) for predicting the development of CMV disease. METHODS: One hundred and thirty one allo-HSCT patients performed in the past 2 years were analyzed retrospectively. PCR-CMV was used to monitor CMV viremia and vireuria once a week after transplantation. RESULTS: In the dynamic detection, CMV viremia was positive for at least one chance in 89 patients, vireuria did in 99 patients. Thirty-seven patients developed CMV disease with an accumulative incidence of 32.5%. The incidence of CMV disease was 15.6% in plasma CMV-PCR negative group, 31.3% in positive once group, and 47.3% in positive over twice group. There was significant difference among the three groups (P = 0.0126). The incidence of CMV disease was 24.8% in urine CMV-PCR negative group, 43.5% in positive once group, and 33.0% in positive over twice group, being no significant difference among them (P = 0.845). On analysis, viremia could predict the development of CMV disease: the PPV (positive predictive value) is 40.5%, NPV (negative predictive value) is 84.4%, sensitivity is 75.0%, and specificity is 69.2%. CONCLUSIONS: Detected by CMV-PCR, MCV viremia may predict the development of CMV disease, but MCV vireuria cannot.
    [Abstract] [Full Text] [Related] [New Search]